Therapy for muscular dystrophy: A new start-up
To date, there is no treatment for this life-threatening genetic disease
02-Mar-2022 -
Prof. Markus Rüegg and Dr. Judith Reinhard from the Biozentrum of the University of Basel have founded the start-up SEAL Therapeutics AG together with Dr. Thomas Meier, former CEO of Santhera Pharmaceuticals. Their goal is to treat congenital muscular dystrophy using gene therapy and to bring ...
gene therapy
hereditary diseases
muscle distrophy